It wasn't just lower-than-expected earnings that hurt the medical device company. Without new acquisitions to improve margins, the company has primarily focused on organic growth. For some of its ...

With the preannouncement of revenue missing guidance last month, Natus Medical's (NASDAQ: BABY) fourth-quarter report this week wasn't particularly surprising. Fortunately, the medical-supply company ...

Another key partner joins the Otocloud community, expanding the reach even further. ReSound is officially accepting Otoscan files! PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Natus Medical ...

Natus Medical (NASDAQ: BABY) posted solid fourth-quarter revenue, which slightly beat the guidance management gave last quarter. Granted, it was a jump over a lowered bar, but the $530.9 million in ...

Natus Medical (NASDAQ: NTUS) continues its revamping, complete with a new ticker. While the old "BABY" ticker was a great pun for its legacy business, Natus has expanded well beyond its newborn ...

Natus Medical (NASDAQ: BABY) continued its slow-but-steady growth in the third quarter with newly acquired business and new products making up for some headwinds for the legacy part of its business.

Natus has generally been an acquisitive company, with a strategy of growing through small tuck-in or bolt-on acquisitions that could help it improve its margins. But in recent years, those ...